DNA & Genetics Korro Craters 81% on Data; Patient Death Sours Analysts on IntelliaBy adminNovember 18, 20250 Korro Bio (NASDAQ: KRRO) saw its stock reach its first of two all-time lows, cratering 81% Thursday after reporting disappointing…
DNA & Genetics Analysts See Pain, and Necessity, in Novo Nordisk’s 9,000 LayoffsBy adminSeptember 14, 20250 Novo Nordisk (NASDAQ Copenhagen: NOVO-B) inflicted much pain—and much-needed pain—on the company when president and CEO Maziar (Mike) Doustdar announced…
